Fresenius looks to continue acquisitive stride in Brazil in coming year
Fresenius [ETR:FME] will continue its acquisitive pace in Brazil next year, O Estado de São Paulo reported, without citing a source for the information.
The German provider of products and services for patients with kidney diseases made eight buys in Brazil this year, as part of its plan to invest BRL 300m (USD 76.7m) in the country until 2020, the Portuguese-language paper said.